DK358889D0 - MACROCYCLIC POLYAZA COMPOUNDS CONTAINING A 5- OR 6-RING RING, METHOD OF PREPARING THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS - Google Patents

MACROCYCLIC POLYAZA COMPOUNDS CONTAINING A 5- OR 6-RING RING, METHOD OF PREPARING THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS

Info

Publication number
DK358889D0
DK358889D0 DK358889A DK358889A DK358889D0 DK 358889 D0 DK358889 D0 DK 358889D0 DK 358889 A DK358889 A DK 358889A DK 358889 A DK358889 A DK 358889A DK 358889 D0 DK358889 D0 DK 358889D0
Authority
DK
Denmark
Prior art keywords
group
radical
atom
image
hydrogen
Prior art date
Application number
DK358889A
Other languages
Danish (da)
Other versions
DK358889A (en
DK171097B1 (en
Inventor
Johannes Platzek
Bernd Raduechel
Heinz Gries
Hans-Joachim Weinmann
Ulrich Speck
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK358889D0 publication Critical patent/DK358889D0/en
Publication of DK358889A publication Critical patent/DK358889A/en
Application granted granted Critical
Publication of DK171097B1 publication Critical patent/DK171097B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/04Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Macrocyclic compounds of the general formula I <IMAGE> in which @is a single or double bond, q is the numbers 0-5, A and B, which are identical or different, are each a straight-chain or branched alkylene group with 2 to 6 carbon atoms, D is a nitrogen, oxygen atom, the group =C=O, =NR<2> with R<2> being a hydrogen atom or a C1-C6-alkyl group, the group <IMAGE> with R<3> being a hydrogen or halogen atom, a phenyl, a C1-C6-alkyl group which is optionally substituted by one or more phenyl and/or hydroxyl group(s), being the radical OR<5> where R<5> is a C1-C6-alkyl radical which is optionally substituted by 1 to 3 hydroxyl groups, being the substituent <IMAGE> where l is the numbers 0 and 1 and R<6> and R<7> are, independently of one another, hydrogen atoms, the radical R<5>, phenyl or benzyl radicals which are optionally substituted by 1 to 3 hydroxyl groups, or R<6> and R<7> are, together with the nitrogen atom, a saturated or unsaturated, 5- or 6-membered ring which optionally contains another nitrogen, oxygen, sulphur atom or a carbonyl group and which is optionally substituted by 1 to 3 radicals R<5>, or one of the substituents R<6> or R<7> is the radical <IMAGE> or being the substituent G where G is a second macrocycle which is bonded via a direct bond, a bis(carbonylamino) group (-NH-CO-CO-NH-) or via a C1-C20-alkylene group which optionally carries at the ends carbonyl (> CO) or carbonylamino (-NH-CO-) groups or oxygen atoms and optionally contains one or more oxygen atom(s), Z-, acyl- or hydroxyacyl-substituted imino groups or one to two C-C double and/or C-C triple bonds, and has the general formula II <IMAGE> in which D<1> has the same meaning as D with the exception that D<1> does not contain the substituent G, or is the radical -CH-, =C- or -N- and F<1> has the same meaning as F with the exception that F<1> does not contain the substituent G, or is the radical -CH-, or =C-, E is a nitrogen, sulphur, oxygen atom, the <IMAGE> or >NR<4> group with R<4> being a hydroxyl group, being R<2> or being an optionally hydroxylated or carboxylated C1-C6-alkyl group, F is (-CHR<8>-)n or (=CR<8>)n with n being the numbers 0 or 1 and R<8> being R<1> or G, R<1> is a hydrogen or halogen atom or a C1-C6-alkyl group, Z is a hydrogen atom or the group -CH2COOY with Y being a hydrogen atom and/or a metal ion equivalent of an element of atomic numbers 21-29, 31, 32, 37-39, 42-44, 49 or 57-83, with the proviso that at least two of the substituents Z are the radical -CH2COOY and that the macrocyclic compound of the general formula I does not contain more than one radical G, and the salts thereof with inorganic and/or organic bases, amino acids or amino amides are valuable diagnostic and therapeutic agents.
DK358889A 1988-07-20 1989-07-19 Metal complexes of di- and tri (carboxymethyl) tri and tetra (azabicycloalkane) derivatives and salts thereof, pharmaceutical agents containing these compounds, the use of the compounds for the preparation of agents for NMR X-ray or radio diagnostics or or radiation therapy as well as the method of preparing the compounds DK171097B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3825040 1988-07-20
DE3825040A DE3825040A1 (en) 1988-07-20 1988-07-20 5- OR 6-RING MACROCYCLIC POLYAZA COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM

Publications (3)

Publication Number Publication Date
DK358889D0 true DK358889D0 (en) 1989-07-19
DK358889A DK358889A (en) 1990-01-21
DK171097B1 DK171097B1 (en) 1996-06-03

Family

ID=6359368

Family Applications (1)

Application Number Title Priority Date Filing Date
DK358889A DK171097B1 (en) 1988-07-20 1989-07-19 Metal complexes of di- and tri (carboxymethyl) tri and tetra (azabicycloalkane) derivatives and salts thereof, pharmaceutical agents containing these compounds, the use of the compounds for the preparation of agents for NMR X-ray or radio diagnostics or or radiation therapy as well as the method of preparing the compounds

Country Status (15)

Country Link
EP (1) EP0352218B1 (en)
JP (1) JP2877844B2 (en)
AT (1) ATE118775T1 (en)
CA (1) CA1341035C (en)
DE (2) DE3825040A1 (en)
DK (1) DK171097B1 (en)
ES (1) ES2068908T3 (en)
FI (1) FI893509A (en)
GR (1) GR3015162T3 (en)
IE (1) IE66693B1 (en)
IL (1) IL91046A (en)
NO (1) NO179104C (en)
NZ (1) NZ229996A (en)
PT (1) PT91211B (en)
ZA (1) ZA895543B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334371A (en) * 1988-07-20 1994-08-02 Schering Aktiengesellschaft Marcocyclic polyaza bicyclo compounds containing 5 or 6 membered rings, and method for MRI
DE4001655A1 (en) * 1990-01-18 1991-07-25 Schering Ag 6-RING MACROCYCLIC TETRAAZA COMPOUNDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL PRODUCTS CONTAINING THEM
BR9007009A (en) * 1989-01-17 1991-11-12 Xyrofin Oy PROCESS FOR THE PRODUCTION OF XYLITOL FROM AQUEOUS XYLOSE SOLUTION
FR2652589B1 (en) * 1989-10-04 1995-02-17 Roquette Freres PROCESS FOR THE MANUFACTURE OF XYLITOL AND XYLITOL-RICH PRODUCTS.
WO1991010669A1 (en) * 1990-01-19 1991-07-25 Cockbain, Julian, Roderick, Michaelson Chelating compounds
GB9001245D0 (en) * 1990-01-19 1990-03-21 Salutar Inc Compounds
US5330737A (en) * 1991-12-06 1994-07-19 Mallinckrodt Medical, Inc. Nitrogen-sulfur ligands as opiate receptor drug mimics
US5480990A (en) * 1991-12-10 1996-01-02 The Dow Chemical Company Bicyclopolyazamacrocyclocarboxylic acid complexes for use as contrast agents
DK0570575T3 (en) * 1991-12-10 1998-08-24 Dow Chemical Co Bicycloazamacrocyclophosphonic acid, complexes, conjugates, contrast agents and preparation thereof
US5739294A (en) * 1991-12-10 1998-04-14 The Dow Chemical Company Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents
WO1994026313A1 (en) * 1993-05-06 1994-11-24 The Dow Chemical Company Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents
EP0579802B1 (en) * 1991-12-10 2000-04-26 The Dow Chemical Company Bicycle-polyazamacrocyclocarboxylic acid complexes, conjugates, preparation and use as contrast agents
WO1993012112A1 (en) * 1991-12-10 1993-06-24 The Dow Chemical Company Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates processes for their preparation, and use as radiopharmaceuticals
US5428139A (en) * 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
AU4237493A (en) * 1993-05-06 1994-12-12 Dow Chemical Company, The Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as radiopharmaceuticals
US5385893A (en) * 1993-05-06 1995-01-31 The Dow Chemical Company Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
US5480970A (en) * 1993-12-22 1996-01-02 Resolution Pharmaceuticals Metal chelators
US5569745A (en) * 1994-02-25 1996-10-29 Resolution Pharmaceuticals Inc. Peptide-Chelator conjugates
EP0898574B1 (en) * 1996-04-19 2003-11-12 Dow Global Technologies Inc. Fluorescent chelates as visual tissue specific imaging agents
FR2794744B1 (en) * 1999-06-09 2001-09-21 Guerbet Sa METAL COMPLEXES OF BICYCLIC POLYAMINOACIDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN MEDICAL IMAGING
EP1322340A2 (en) * 2000-09-25 2003-07-02 The Procter & Gamble Company Manganese complexes for magnetic resonance imaging
CA2625196C (en) * 2005-10-07 2016-04-05 Guerbet Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium
US8986650B2 (en) 2005-10-07 2015-03-24 Guerbet Complex folate-NOTA-Ga68
FR2891830B1 (en) * 2005-10-07 2011-06-24 Guerbet Sa SHORT AMINOALCOHOL COMPOUNDS AND METAL COMPLEXES FOR MEDICAL IMAGING
GB201610738D0 (en) 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
US11110186B2 (en) * 2017-12-20 2021-09-07 General Electric Company Anionic chelate compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2478456A (en) 1946-03-15 1949-08-09 Socony Vaeuum Oil Company Inc Solvent dewaxing
US3194818A (en) 1963-08-14 1965-07-13 Sterling Drug Inc Alpha-aryl or aralkyl furfurylamines
DE3129906C3 (en) * 1981-07-24 1996-12-19 Schering Ag Paramagnetic complex salts, their preparation and agents for use in NMR diagnostics
DE3150917A1 (en) 1981-12-18 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen "2-AMINO-1- (1,3-DIOXOLAN-4-YL) -ETHANOL COMPOUNDS, THEIR PRODUCTION AND USE FOR PROCESSING"
NL194579C (en) * 1983-01-21 2002-08-05 Schering Ag Diagnostic.
DE3324235A1 (en) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen NEW COMPLEX ILLUMINATORS, COMPLEX AND COMPLEX SALTS
SE8502573D0 (en) * 1985-05-23 1985-05-23 Jouko Kanakre FLUORESCENT LANTHANIDE CHELATES USEFUL AS LABELS OF PHYSIOLOGICALLY ACTIVE MATERIALS
DE3772785D1 (en) 1986-01-23 1991-10-17 Squibb & Sons Inc 1-SUBSTITUTED-4,7,10-TRISCARBOXYMETHYL-1,4,7,10-TETRAAZACYCLODODECAN AND ANALOG.

Also Published As

Publication number Publication date
FI893509A (en) 1990-01-21
IE892335L (en) 1990-01-20
DE3825040A1 (en) 1990-01-25
ES2068908T3 (en) 1995-05-01
PT91211B (en) 1995-03-01
FI893509A0 (en) 1989-07-20
JP2877844B2 (en) 1999-04-05
DK358889A (en) 1990-01-21
ZA895543B (en) 1990-05-30
AU637052B2 (en) 1993-05-20
ATE118775T1 (en) 1995-03-15
DK171097B1 (en) 1996-06-03
NO179104B (en) 1996-04-29
JPH02104588A (en) 1990-04-17
NO892959L (en) 1990-01-22
DE58909022D1 (en) 1995-04-06
AU3827589A (en) 1990-02-01
CA1341035C (en) 2000-06-20
EP0352218A3 (en) 1991-01-16
IE66693B1 (en) 1996-01-24
GR3015162T3 (en) 1995-05-31
PT91211A (en) 1990-02-08
NZ229996A (en) 1992-05-26
NO892959D0 (en) 1989-07-19
EP0352218A2 (en) 1990-01-24
NO179104C (en) 1996-08-07
IL91046A (en) 1995-10-31
EP0352218B1 (en) 1995-02-22
IL91046A0 (en) 1990-02-09

Similar Documents

Publication Publication Date Title
DK358889A (en) MACROCYCLIC POLYAZA COMPOUNDS CONTAINING A 5- OR 6-RING RING, METHOD OF PREPARING THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS
ES2091865T3 (en) TETRAAZA-MACROCYCLIC COMPOUNDS CONTAINING 6 RINGS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THEM.
FR2662162B1 (en) NOVEL DERIVATIVES OF AMINO PIPERIDINE, AMINO PYRROLIDINE AND AMINO PERHYDROAZEPINE, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES8605237A1 (en) 1,3,4,5-Tetrahydrobenzo(c,d)indoles, process for their preparation and their uses.
DE69305276T2 (en) Arylglycinamide derivatives, processes for their preparation and their use in the therapy of dysuria
WO1994013658A3 (en) Benzocycloheptenes, benzoxepines and benzothiepines
NO304114B1 (en) Taxane derivatives and their preparation
DE69625795D1 (en) Thiazolidinedione derivatives with antidiabetic, hypolipidemic and antihypertensive properties, processes for their preparation and pharmaceutical compositions containing them
NO179835C (en) Amine derivatives with fungicidal activity and use as fungicides

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed